Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease in Conjunction With Long-term Outcome

NCT03108326 is registered in ClinicalTrials.gov with Ced Service GmbH as lead sponsor.

NCT NCT03108326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03108326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease in Conjunction With Long-term Outcome
Lead sponsor
Ced Service GmbH
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2017
Completion date
March 31, 2023
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease